Announced details
Cosmetics and anti-aging care products for skin and hair
Particles approximately 100 nm in diameter. Uptake by human dermal fibroblasts and accumulation and colocalization in the vicinity of mitochondria were confirmed. The results indicated the potential to suppress increases in mitochondrial reactive oxygen species in cells exposed to oxidative stress.
Joint research with the company’s subsidiary, 株式会社アジュバンコスメジャパン. Joint research began in February 2022.
Professor at Hokkaido University’s Graduate School of Pharmaceutical Sciences. Other information, including location, representative, capital and year of establishment, is Not disclosed
Patent registration No. 5067733 (MITO-Porter)
株式会社アジュバンコスメジャパン: Chuo-ku, Kobe, Hyogo Prefecture
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
Related research presented at the 145th Annual Meeting of the Pharmaceutical Society of Japan (March 2025, Fukuoka)
| Item | Details |
|---|---|
| Names of Products / Services Covered | Nanoscale particles for cosmetic use (based on the MITO-Porter delivery concept) |
| Counterparty | National University Corporation Hokkaido University, Graduate School of Pharmaceutical Sciences, Professor Yamada Yuma (山田勇磨) |
| Counterparty overview | Professor at Hokkaido University’s Graduate School of Pharmaceutical Sciences. Other information, including location, representative, capital and year of establishment, is Not disclosed |
| Relationship with the Company | Joint research with the company’s subsidiary, 株式会社アジュバンコスメジャパン. Joint research began in February 2022. |
| Contract Date | February 2022 (start of joint research) |
| Applicable area | Cosmetics and anti-aging care products for skin and hair |
| Registration number and expiry date | Patent registration No. 5067733 (MITO-Porter) |
| Location | 株式会社アジュバンコスメジャパン: Chuo-ku, Kobe, Hyogo Prefecture |
| Quantitative Effects | Particles approximately 100 nm in diameter. Uptake by human dermal fibroblasts and accumulation and colocalization in the vicinity of mitochondria were confirmed. The results indicated the potential to suppress increases in mitochondrial reactive oxygen species in cells exposed to oxidative stress. |
| Source | Related research presented at the 145th Annual Meeting of the Pharmaceutical Society of Japan (March 2025, Fukuoka) |
Items this document does not state (8)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The project focused on the close relationship between declining mitochondrial function and the aging process. A technology was needed to deliver “Ingredient X” efficiently so that it could exert its function in mitochondria.